Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

2.

Second-generation long-acting injectable antipsychotic agents: an overview.

[No authors listed]

Drug Ther Bull. 2012 Sep;50(9):102-5. doi: 10.1136/dtb.2012.08.0127. Review.

PMID:
22966099
3.

Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Brewerton TD.

Curr Psychiatry Rep. 2012 Aug;14(4):398-405. doi: 10.1007/s11920-012-0287-6. Review.

PMID:
22628000
4.

Antipsychotic agents: efficacy and safety in schizophrenia.

de Araújo AN, de Sena EP, de Oliveira IR, Juruena MF.

Drug Healthc Patient Saf. 2012;4:173-80. doi: 10.2147/DHPS.S37429. Epub 2012 Nov 29.

5.
6.

Risk of venous thromboembolism during treatment with antipsychotic agents.

Masopust J, Malý R, Vališ M.

Psychiatry Clin Neurosci. 2012 Dec;66(7):541-52. doi: 10.1111/pcn.12001. Review.

7.

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.

J Clin Psychiatry. 2009 Jun;70(6):863-8. doi: 10.4088/JCP.08m04369. Epub 2009 May 5.

PMID:
19422759
8.

Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.

Chatterjee S, Chen H, Johnson ML, Aparasu RR.

Am J Geriatr Pharmacother. 2012 Apr;10(2):83-94. doi: 10.1016/j.amjopharm.2011.10.006. Epub 2012 Feb 10.

PMID:
22306198
9.

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M.

J Clin Psychopharmacol. 2004 Feb;24(1):62-9.

PMID:
14709949
10.

Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.

Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH.

Neurosci Biobehav Rev. 2013 Jul;37(6):1162-71. doi: 10.1016/j.neubiorev.2012.09.008. Epub 2012 Oct 23. Review.

11.

Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study.

Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M.

J Psychopharmacol. 2013 Apr;27(4):349-57. doi: 10.1177/0269881112463470. Epub 2012 Oct 24.

PMID:
23095245
12.

Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents.

Doyle OM, De Simoni S, Schwarz AJ, Brittain C, O'Daly OG, Williams SC, Mehta MA.

J Pharmacol Exp Ther. 2013 Apr;345(1):151-60. doi: 10.1124/jpet.112.201665. Epub 2013 Jan 31.

13.
14.

The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.

Ehret M, Goethe J, Lanosa M, Coleman CI.

J Clin Psychiatry. 2010 Oct;71(10):1286-92. doi: 10.4088/JCP.09m05274yel. Epub 2010 Apr 6.

PMID:
20441727
15.
16.

[Antipsychotic agents in the treatment of somatoform disorders; a review].

Decoutere L, van den Eede F, Moorkens G, Sabbe BG.

Tijdschr Psychiatr. 2011;53(3):163-73. Review. Dutch.

17.

[The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].

van den Heuvel OA, Bet PM, van Dam EW, Eeckhout AM.

Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1944-8. Dutch.

PMID:
16999280
18.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
19.

Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.

Kagal UA, Torgal SS, Patil NM, Malleshappa A.

J Pharm Pract. 2012 Jun;25(3):368-73. doi: 10.1177/0897190012442220. Epub 2012 May 2.

PMID:
22551560
20.

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

Edwards NC, Locklear JC, Rupnow MF, Diamond RJ.

Pharmacoeconomics. 2005;23 Suppl 1:75-89.

PMID:
16416763

Supplemental Content

Support Center